We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+9.91%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$60.5M
AUM Growth
-$9.67M
Cap. Flow
-$7.48M
Cap. Flow %
-12.38%
Top 10 Hldgs %
86.75%
Holding
30
New
2
Increased
1
Reduced
3
Closed
9

Top Buys

Rank Stock Value
1
ASRT
Assertio
ASRT
+$3.75M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$454K
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$215K

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.36M
2
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
+$1.43M
3
ABBV icon
AbbVie
ABBV
+$1.36M
4
ADYX
Adynxx Inc
ADYX
+$1.33M
5
AEGR
Aegerion Pharmaceuticals
AEGR
+$680K

Sector Composition

Rank Sector Weight
1 Healthcare 85.46%
2 Miscellaneous 14.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIM
26
DELISTED
Alimera Sciences
ALIM
– –
-6,667
Closed -$221K
STML
27
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-25,000
Closed -$221K
ADYX
28
DELISTED
Adynxx Inc
ADYX
– –
-7,017
Closed -$1.33M
ARIA
29
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-50,000
Closed -$292K
AEGR
30
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-50,000
Closed -$680K
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Healthcare Value Capital held 30 positions worth $60.5M, down 14% from $70.1M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Healthcare Value Capital withdrew a net $7.48M in Q4 2015, closing 9 positions and reducing 3 holdings. Its most notable exit was AstraZeneca, an estimated $6.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 77% a quarter earlier, followed by Miscellaneous.

Against the trend, Healthcare Value Capital opened a new position in Assertio worth $3.63M.

  • Healthcare Value Capital's largest Q4 2015 buy was Assertio: 3,333 shares worth $3.63M.
  • Healthcare Value Capital added most to ANI Pharmaceuticals in Q4 2015, an estimated $215K increase.
  • Healthcare Value Capital fully exited AstraZeneca in Q4 2015, selling an estimated $6.36M.
  • Healthcare Value Capital's ten largest holdings make up 87% of its $60.5M portfolio in Q4 2015.
  • Healthcare Value Capital opened 2 new positions and closed 9 in Q4 2015.
  • Healthcare Value Capital's portfolio value fell 14% quarter-over-quarter to $60.5M.

Based on Healthcare Value Capital's 13F filing for Q4 2015, filed 16 Feb 2016.